Currently, there are 197.84M common shares owned by the public and among those 197.57M shares have been available to trade.
The company’s stock has a 5-day price change of -11.08% and -16.35% over the past three months. ZBH shares are trading -14.34% year to date (YTD), with the 12-month market performance down to -24.32% lower. It has a 12-month low price of $93.10 and touched a high of $122.25 over the same period. ZBH has an average intraday trading volume of 2.17 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -9.89%, -14.26%, and -15.58% respectively.
Institutional ownership of Zimmer Biomet Holdings Inc (NYSE: ZBH) shares accounts for 93.20% of the company’s 197.84M shares outstanding.
It has a market capitalization of $17.90B and a beta (3y monthly) value of 0.78. The stock’s trailing 12-month PE ratio is 20.06, while the earnings-per-share (ttm) stands at $4.51. The company has a PEG of 3.98 and a Quick Ratio of 1.46 with the debt-to-equity ratio at 0.58. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.92% over the week and 3.74% over the month.
Earnings per share for the fiscal year are expected to increase by 0.62%, and 4.98% over the next financial year. EPS should grow at an annualized rate of 5.04% over the next five years, compared to -4.13% over the past 5-year period.
Looking at the support for the ZBH, a number of firms have released research notes about the stock. JP Morgan stated their Overweight rating for the stock in a research note on December 17, 2024, with the firm’s price target at $125-$128. Piper Sandler was of a view on July 01, 2024 that the stock is Neutral, while Goldman gave the stock Neutral rating on May 30, 2024, issuing a price target of $129. Argus on their part issued Buy rating on May 21, 2024.
